Help
RSS
API
Feed
Maltego
Contact
Domain > ir.propanc.com
×
More information on this domain is in
AlienVault OTX
Is this malicious?
Yes
No
DNS Resolutions
Date
IP Address
2019-04-27
34.192.54.34
(
ClassC
)
2020-07-18
54.227.147.28
(
ClassC
)
2021-09-12
3.221.176.71
(
ClassC
)
2026-02-23
52.52.175.53
(
ClassC
)
Port 443
HTTP/1.1 200 OKDate: Mon, 23 Feb 2026 07:23:16 GMTServer: ApacheVary: Accept-EncodingTransfer-Encoding: chunkedContent-Type: text/html; charsetUTF-8 !DOCTYPE html>!--if lt IE 7> html classno-js lt-ie9 lt-ie8 lt-ie7 langen> !endif-->!--if IE 7> html classno-js lt-ie9 lt-ie8 langen> !endif-->!--if IE 8> html classno-js lt-ie9 langen> !endif-->!--if gt IE 8>!--> html classno-js langen> !--!endif--> head>base hrefhttps://www.propanc.com />link hrefhttps://ir.propanc.com/stylesheets/ir.stockpr.css relstylesheet typetext/css mediascreen />link relalternate typeapplication/rss+xml titlePropanc Biopharma, Inc.(PPCB) - Recent News hrefhttps://ir.propanc.com/rss />script typetext/javascript srchttps://ir.propanc.com/javascripts/ir.js>/script> meta charsetutf-8> title>Investor Relations :: Propanc Biopharma, Inc. (PPCB)/title> meta propertyog:site_name contentPropanc Biopharma, Inc.> meta propertyog:title contentInvestor Relations :: Propanc Biopharma, Inc. (PPCB)> meta propertyog:type contentwebsite> meta propertyog:image contenthttps://d1io3yog0oux5.cloudfront.net/_061ec00376ee1bd8e8da4852d9bac859/propanc/files/theme/images/logo.png> meta propertyog:url contenthttps://ir.propanc.com> meta nameviewport contentinitial-scale1.0, widthdevice-width> link hrefhttps://fonts.googleapis.com/css?familyLato:400,400italic,300,700 relstylesheet typetext/css> link relstylesheet hrefhttps://d1io3yog0oux5.cloudfront.net/_061ec00376ee1bd8e8da4852d9bac859/propanc/files/theme/css/style.css> link relshortcut icon hrefhttps://d1io3yog0oux5.cloudfront.net/_061ec00376ee1bd8e8da4852d9bac859/propanc/files/theme/images/favicons/favicon.ico> link relicon typeimage/png hrefhttps://d1io3yog0oux5.cloudfront.net/_061ec00376ee1bd8e8da4852d9bac859/propanc/files/theme/images/favicons/favicon-16x16.png sizes16x16> link relicon typeimage/png hrefhttps://d1io3yog0oux5.cloudfront.net/_061ec00376ee1bd8e8da4852d9bac859/propanc/files/theme/images/favicons/favicon-32x32.png sizes32x32> link relapple-touch-icon hrefhttps://d1io3yog0oux5.cloudfront.net/_061ec00376ee1bd8e8da4852d9bac859/propanc/files/theme/images/favicons/apple-touch-icon-precomposed.png> link relapple-touch-icon hrefhttps://d1io3yog0oux5.cloudfront.net/_061ec00376ee1bd8e8da4852d9bac859/propanc/files/theme/images/favicons/apple-touch-icon.png> link relapple-touch-icon sizes57x57 hrefhttps://d1io3yog0oux5.cloudfront.net/_061ec00376ee1bd8e8da4852d9bac859/propanc/files/theme/images/favicons/apple-touch-icon-57x57.png> link relapple-touch-icon sizes60x60 hrefhttps://d1io3yog0oux5.cloudfront.net/_061ec00376ee1bd8e8da4852d9bac859/propanc/files/theme/images/favicons/apple-touch-icon-60x60.png> link relapple-touch-icon sizes72x72 hrefhttps://d1io3yog0oux5.cloudfront.net/_061ec00376ee1bd8e8da4852d9bac859/propanc/files/theme/images/favicons/apple-touch-icon-72x72.png> link relicon typeimage/png hrefhttps://d1io3yog0oux5.cloudfront.net/_061ec00376ee1bd8e8da4852d9bac859/propanc/files/theme/images/favicons/android-chrome-36x36.png sizes36x36> link relicon typeimage/png hrefhttps://d1io3yog0oux5.cloudfront.net/_061ec00376ee1bd8e8da4852d9bac859/propanc/files/theme/images/favicons/android-chrome-48x48.png sizes48x48> link relicon typeimage/png hrefhttps://d1io3yog0oux5.cloudfront.net/_061ec00376ee1bd8e8da4852d9bac859/propanc/files/theme/images/favicons/android-chrome-72x72.png sizes72x72> link relmask-icon hrefhttps://d1io3yog0oux5.cloudfront.net/_061ec00376ee1bd8e8da4852d9bac859/propanc/files/theme/images/favicons/safari-pinned-tab.svg> meta namemsapplication-TileColor content#ffffff> meta namemsapplication-TileImage contenthttps://d1io3yog0oux5.cloudfront.net/_061ec00376ee1bd8e8da4852d9bac859/propanc/files/theme/images/favicons/mstile-70x70.png> meta namemsapplication-TileImage contenthttps://d1io3yog0oux5.cloudfront.net/_061ec00376ee1bd8e8da4852d9bac859/propanc/files/theme/images/favicons/mstile-150x150.png> meta namemsapplication-TileImage contenthttps://d1io3yog0oux5.cloudfront.net/_061ec00376ee1bd8e8da4852d9bac859/propanc/files/theme/images/favicons/mstile-310x150.png> link relmanifest hrefhttps://d1io3yog0oux5.cloudfront.net/_061ec00376ee1bd8e8da4852d9bac859/propanc/files/theme/images/favicons/manifest.json> meta namemsapplication-config contenthttps://d1io3yog0oux5.cloudfront.net/_061ec00376ee1bd8e8da4852d9bac859/propanc/files/theme/images/favicons/browserconfig.xml> !--if lt IE 9>link relstylesheet hrefhttps://d1io3yog0oux5.cloudfront.net/_061ec00376ee1bd8e8da4852d9bac859/propanc/files/theme/css/ie-8.css>!endif--> script> (function(i,s,o,g,r,a,m){iGoogleAnalyticsObjectr;irir||function(){ (ir.qir.q||).push(arguments)},ir.l1*new Date();as.createElement(o), ms.getElementsByTagName(o)0;a.async1;a.srcg;m.parentNode.insertBefore(a,m) })(window,document,script,https://www.google-analytics.com/analytics.js,ga); ga(create, UA-71515148-1, propanc.com); (function() { var opts {}; var prefix /investor-relations; if (location.hostname.indexOf(dev-ir.stockpr.com) 0) { opts.cookiePath location.pathname.substring(0, location.pathname.indexOf(/, 1) + 1) opts.page prefix + location.pathname.substring(location.pathname.indexOf(/, 1)); } else if (location.hostname.match(/^ir\./)) { opts.page prefix + location.pathname; } ga(send, pageview, opts); })();/script> /head>body classpg-105518 -pg ir> div classgeneral-wrapper> header classbig-header> div classcontainer> h1 classlogo> a href/> img srchttps://d1io3yog0oux5.cloudfront.net/_061ec00376ee1bd8e8da4852d9bac859/propanc/files/theme/images/header-logo.svg width240 height50 altPropanc Biopharma, Inc.> /a> /h1> a classvisible-xs mobile-nav-trigger idshowRight> div classmeat>/div> div classmeat>/div> div classmeat>/div> /a> nav classcbp-spmenu cbp-spmenu-vertical cbp-spmenu-right main-nav idmobile-nav> ul classmain-menu> li classsr-only>a href/>Home/a>/li> li classhas-children data-submenu-idsubmenu-about> a href/about>About/a> ul idsubmenu-about> li class >a href/about>Overview/a>/li> li class >a href/about/mission-and-vision>Mission and Vision/a>/li> li class >a href/about/market-need>Market Need/a>/li> li class >a href/about/propanc-difference>Propanc Difference/a>/li> li class >a href/about/management-team>Management Team/a>/li> li class >a href/about/board-of-directors>Board of Directors/a>/li> li class >a href/about/scientific-advisors>Scientific Advisors/a>/li> /ul> /li> li classhas-children data-submenu-idsubmenu-product-pipeline> a href/product-pipeline>Product Pipeline/a> ul idsubmenu-product-pipeline> li class >a href/product-pipeline>Overview/a>/li> li class >a href/product-pipeline/prp>PRP/a>/li> /ul> /li> li class data-submenu-idsubmenu-technology> a href/technology>Technology/a> /li> li classhas-children data-submenu-idsubmenu-news-media> a href/news-media>News & Media/a> ul idsubmenu-news-media> li class >a href/news-media/press-releases>Press Releases/a>/li> li class >a href/news-media/publications>Publications/a>/li> li class >a href/news-media/videos>Videos/a>/li> li class >a href/news-media/in-the-news>In The News/a>/li> /ul> /li> li classhas-children has-mega-menu active data-submenu-idsubmenu-investors> a href/investors>Investors/a> div classmega-menu second-level same-height-row-disabled> div classcontainer> ul classheight> li classtitle>a href/investors>Investor Relations/a>/li> li>a href/investors/_>Overview/a>/li> /ul> ul classheight> li classtitle>a href/investors/news-events>News / Events/a>/li> li>a href/investors/news-events/news-events>News / Events/a>/li> li>a href/investors/news-events/press-releases>Press Releases/a>/li> li>a href/investors/news-events/presentations>Presentations/a>/li> li>a href/investors/news-events/ir-calendar>IR Calendar/a>/li> li>a href/investors/news-events/email-alerts>Email Alerts/a>/li> /ul> ul classheight> li classtitle>a href/investors/company-information>Company Info/a>/li> li>a href/investors/company-information/company-information>Company Information/a>/li> li>a href/investors/company-information/profile>Profile/a>/li> li>a href/investors/company-information/management-team>Management Team/a>/li> li>a href/investors/company-information/contacts>Contacts/a>/li> li>a href/investors/company-information/faq>FAQ/a>/li> /ul> ul classheight> li classtitle>a href/investors/financial-information>Financial Info/a>/li> li>a href/investors/financial-information/financial-information>Financial Information/a>/li> li>a href/investors/financial-information/financials>Financials/a>/li> li>a href/investors/financial-information/financial-results>Financial Results/a>/li> /ul> ul classheight> li classtitle>a href/investors/stock-data>Stock Data/a>/li> li>a href/investors/stock-data/stock-data>Stock Data/a>/li> li>a href/investors/stock-data/quote>Quote/a>/li> li>a href/investors/stock-data/charts>Charts/a>/li> li>a href/investors/stock-data/historical-data>Historical Data/a>/li> li>a href/investors/stock-data/form-8937>Form 8937/a>/li> /ul> ul classheight> li classtitle>a href/investors/sec-filings>SEC Filings/a>/li> li>a href/investors/sec-filings/sec-filings>SEC Filings/a>/li> li>a href/investors/sec-filings/all-sec-filings>All SEC Filings/a>/li> li>a href/investors/sec-filings/annual-reports>Annual Reports/a>/li> li>a href/investors/sec-filings/quarterly-reports>Quarterly Reports/a>/li> li>a href/investors/sec-filings/section-16-filings>Section 16 Filings/a>/li> /ul> ul classheight> li classtitle>a href/investors/corporate-governance>Governance/a>/li> li>a href/investors/corporate-governance/corporate-governance>Corporate Governance/a>/li> li>a href/investors/corporate-governance/board-of-directors>Board of Directors/a>/li> li>a href/investors/corporate-governance/board-committees>Board Committees/a>/li> li>a href/investors/corporate-governance/governance-docs>Governance Documents/a>/li> /ul> /div>/div> /li> li class data-submenu-idsubmenu-contact> a href/contact>Contact/a> /li> /ul> /nav> /div>/header>div classpage-hero ir-hero overlay light stylebackground: url(https://d1io3yog0oux5.cloudfront.net/_061ec00376ee1bd8e8da4852d9bac859/propanc/files/theme/images/hero-investors.jpg);background-position: 50% 50%;background-repeat: no-repeat;background-size: cover;> div classcontainer> div classrow js-same-height-row> div classcol-sm-6 col-md-5> div classtext dark> h2 classtitle>Investors/h2> p>/p> /div> /div> div classcol-sm-6 col-md-7> div classtext dark> /div> /div> /div> /div> /div> div classsub-navigation ir-navigation> div classcontainer>a classvisible-xs visible-sm mobile-sub-nav-trigger collapsed hrefjavascript:void(0); data-togglecollapse data-target#sub-navigation> div classtrigger-container> div classmeat>/div> div classmeat>/div> div classmeat>/div> /div> Investors/a>nav classcollapse sb-nav clearfix idsub-navigation> h3>span>Investors/span>/h3> ul classir-tools hidden-xs hidden-sm> li classhas-children dropdown-click> a hrefjavascript:void(0); data-toggledropdown>Investor Tools/a> ul classdropdown-menu> li>a hrefhttps://ir.propanc.com/email-alerts classemail>Email Alerts/a>/li> li>a hrefhttps://d1io3yog0oux5.cloudfront.net/_061ec00376ee1bd8e8da4852d9bac859/propanc/files/Tear+Sheet.pdf target_blank titleTear Sheet classsheet>Tear Sheet/a>/li> li>a hrefhttps://ir.propanc.com/contacts classcontacts>Contacts/a>/li> li>a hrefhttps://ir.propanc.com/rss classrss target_blank>RSS News Feed/a>/li> /ul> /li> /ul> ul> li classactive >a href/investors/_ >Overview/a> /li> li class has-children dropdown>a href/investors/news-events >News / Events/a> ul classdropdown-menu> li>a href/investors/news-events/press-releases >Press Releases/a> /li> li>a href/investors/news-events/presentations >Presentations/a> /li> li>a href/investors/news-events/ir-calendar >IR Calendar/a> /li> li>a href/investors/news-events/email-alerts >Email Alerts/a> /li> /ul> /li> li class has-children dropdown>a href/investors/company-information >Company Info/a> ul classdropdown-menu> li>a href/investors/company-information/profile >Profile/a> /li> li>a href/investors/company-information/management-team >Management Team/a> /li> li>a href/investors/company-information/contacts >Contacts/a> /li> li>a href/investors/company-information/faq >FAQ/a> /li> /ul> /li> li class has-children dropdown>a href/investors/financial-information >Financial Info/a> ul classdropdown-menu> li>a href/investors/financial-information/financials >Financials/a> /li> li>a href/investors/financial-information/financial-results >Financial Results/a> /li> /ul> /li> li class has-children dropdown>a href/investors/stock-data >Stock Data/a> ul classdropdown-menu> li>a href/investors/stock-data/quote >Quote/a> /li> li>a href/investors/stock-data/charts >Charts/a> /li> li>a href/investors/stock-data/historical-data >Historical Data/a> /li> li>a href/investors/stock-data/form-8937 >Form 8937/a> /li> /ul> /li> li class has-children dropdown>a href/investors/sec-filings >SEC Filings/a> ul classdropdown-menu> li>a href/investors/sec-filings/all-sec-filings >All SEC Filings/a> /li> li>a href/investors/sec-filings/annual-reports >Annual Reports/a> /li> li>a href/investors/sec-filings/quarterly-reports >Quarterly Reports/a> /li> li>a href/investors/sec-filings/section-16-filings >Section 16 Filings/a> /li> /ul> /li> li class has-children dropdown>a href/investors/corporate-governance > Governance/a> ul classdropdown-menu> li>a href/investors/corporate-governance/board-of-directors >Board of Directors/a> /li> li>a href/investors/corporate-governance/board-committees >Board Committees/a> /li> li>a href/investors/corporate-governance/governance-docs >Governance Documents/a> /li> /ul> /li> /ul>/nav>/div>/div>div classmodule ir-module> div classcontainer> div classrow js-same-height-row ir-news-row> div classcol-md-12> div class latest-news> div classheader> h2 classtitle>Latest News/h2>/div> div classtext bottom-container js-same-height> div classsingle-new> div classdate>time datetime2026-02-18 08:45:00>Feb 18, 2026/time>/div> h3>a hrefhttps://ir.propanc.com/press-releases/detail/187/propanc-biopharma-provides-corporate-update-and-reports>Propanc Biopharma Provides Corporate Update and Reports Half Yearly 2025/26 Results/a>/h3> /div> a hrefhttps://ir.propanc.com/press-releases/detail/187/propanc-biopharma-provides-corporate-update-and-reports classbtn bottom-element>Read Press Release/a> /div>/div> /div> /div> /div>/div> div classmodule ir-module background extra-padding overlay gradient-overlay stylebackground: url(https://d1io3yog0oux5.cloudfront.net/_061ec00376ee1bd8e8da4852d9bac859/propanc/files/theme/images/quarterly-results.jpg);background-position: 50% 50%;background-repeat: no-repeat;background-size: cover;>div classcontainer>div classir-results dark> h2>Latest Financial Results/h2> div classir-results-row> div classtext quarterly-results> div classtext> div classrow> div classcol-sm-12 inline results-info> div classmeta> h3>Q2 2026/h3> p>Quarterly Results/p> div classdate>Ended Dec 31, 2025/div> /div> /div> div classcol-sm-12> div classresult-line> div classpull-right> a hrefhttps://d1io3yog0oux5.cloudfront.net/_061ec00376ee1bd8e8da4852d9bac859/propanc/news/2026-02-18_Propanc_Biopharma_Provides_Corporate_Update_and_187.pdf classlink titlePDF: Propanc Biopharma Provides Corporate Update and Reports Half Yearly 2025/26 Results target_blank> span classeqicon-PDF>/span> PDF /a> a hrefhttps://ir.propanc.com/press-releases/detail/187 titlePropanc Biopharma Provides Corporate Update and Reports Half Yearly 2025/26 Results classlink> span classeqicon-HTML>/span> HTML /a> /div> a hrefhttps://ir.propanc.com/press-releases/detail/187/>Release/a> /div> div classresult-line> div classpull-right> a hrefhttps://ir.propanc.com/all-sec-filings/content/0001493152-26-007052/0001493152-26-007052.pdf title10-Q classlink target_blank>span classeqicon-PDF>/span> PDF/a> a hrefhttps://ir.propanc.com/all-sec-filings/content/0001493152-26-007052/form10-q.htm title10-Q Filing Viewer classlink fancybox fancybox.iframe>span classeqicon-HTML>/span> HTML/a> /div> a hrefhttps://ir.propanc.com/all-sec-filings/content/0001493152-26-007052/form10-q.htm title10-Q Filing Viewer classfancybox fancybox.iframe>10-Q span classsr-only>Filing/span>/a>/div>!-- XBRL -->div classresult-line> div classpull-right> a hrefhttps://ir.propanc.com/all-sec-filings/content/0001493152-26-007052/0001493152-26-007052-xbrl.zip titleDownload Raw XBRL Files classlink target_blank>span classeqicon-ZIP>/span> ZIP/a> a hrefhttps://ir.propanc.com/all-sec-filings/content/0001493152-26-007052/Financial_Report.xls titleXBRL Spreadsheet classlink target_blank>span classeqicon-PDF>/span> XLS/a> a hrefhttps://ir.propanc.com/all-sec-filings/xbrl_doc_only/4151 titleXBRL Viewer classlink fancybox fancybox.iframe>span classeqicon-HTML>/span> HTML/a> /div> a hrefhttps://ir.propanc.com/all-sec-filings/xbrl_doc_only/4151 titleXBRL Viewer classfancybox fancybox.iframe>XBRL/a>/div> /div> /div>/div> /div> /div>/div>/div>/div> div classannual-report-module> div classcontainer> div classrow js-same-height-row> div classcol-sm-6 js-same-height hidden-xs> div classouter-image> img srchttps://d1io3yog0oux5.cloudfront.net/_061ec00376ee1bd8e8da4852d9bac859/propanc/files/theme/images/ir-report.png altLatest Report> /div> /div> div classcol-sm-6 col-xs-12> div classjs-same-height js-height vertical-align> div classwrapper> h2>Latest 10-K/h2> div classdark> a hrefhttps://content.equisolve.net/sec/0001493152-25-016069/form10-k.htm target_blank classbtn>View 10-K/a> /div> /div> /div> /div> /div> /div> /div> div classsubscribe> div classcontainer> div classcenter dark> h2>Sign Up For E-Mail Alerts/h2> a hrefhttps://ir.propanc.com/email-alerts classbtn>Sign Up Today/a> /div> /div>/div>div classmodule extra-padding investor-module ir-module>div classcontainer> div classquote-box module-info-home data-symbolPPCB> h2>Stock Informationspan classmeta>span classtime>/span> | a classcta hrefhttps://ir.propanc.com/quote>View Detailed Stock Info/a>/span>/h2> div classrow> div classcol-sm-4> div classstock-section symbol> span classvalue>Nasdaq: PPCB/span> span classvalue-title>Propanc Biopharma, Inc./span> /div> /div> div classcol-sm-4> div classstock-section price> span classvalue>span classloader>/span>/span> span classvalue-title sr-only hidden-xs hidden-sm>Price/span> /div> /div> div classcol-sm-4> div classstock-section change> span classvalue>span classeqicon-change-02>/span>span classnumber>span classloader>/span>/span> span classpercent>/span>/span> span classvalue-title>Change/span> /div> /div> /div> div classrow> div classcol-sm-4> div classstock-section volume> span classvalue>span classloader>/span>/span> span classvalue-title>Volume/span> /div> /div> div classcol-sm-4> div classstock-section day-range> span classvalue>span classloader>/span>/span> span classvalue-title>Day Range/span> /div> /div> div classcol-sm-4> div classstock-section week-range> span classvalue>span classloader>/span>/span> span classvalue-title>52 Week Range/span> /div> /div> /div> /div> div classcompany-overview> h2>Company Overview/h2> div classrow> div classcol-sm-6 full-left> div classtext> p>Propanc is currently focused on developing new cancer treatments for patients suffering from pancreatic, ovarian and colorectal cancers. We have developed a formulation of anti-cancer compounds which exert a number of effects designed to control or prevent tumors from recurring and spreading throughout the body. Our products involve or employ proenzymes, which are inactive precursors of enzymes./p>a hrefhttps://d1io3yog0oux5.cloudfront.net/_44feb46859c4d1b02c4bc6dd5b22387d/propanc/db/233/633/pdf/Story+board+2019+DEF.pdf classbtn target_blank relnoopener>View Scientific Whitepaper/a> /div> /div> div classcol-sm-6 col-md-5 col-md-offset-1 full-right> div classcenter> a hrefhttps://d1io3yog0oux5.cloudfront.net/_061ec00376ee1bd8e8da4852d9bac859/propanc/db/233/711/pdf/Propanc+Biopharma+Corporate+Presentation.pdf target_blank>img srchttps://d1io3yog0oux5.cloudfront.net/_061ec00376ee1bd8e8da4852d9bac859/propanc/files/theme/images/latest-presentation-laptop.png altInvestor Presentation width426 height237 />/a> a hrefhttps://d1io3yog0oux5.cloudfront.net/_061ec00376ee1bd8e8da4852d9bac859/propanc/db/233/711/pdf/Propanc+Biopharma+Corporate+Presentation.pdf target_blank classbtn>View Investor Presentation/a> /div> /div> /div> /div> /div>/div>div classimage-links-module investors-link> div classcontainer-fluid> div classrow> div classcol-sm-6 overlay stylebackground: url(https://d1io3yog0oux5.cloudfront.net/_061ec00376ee1bd8e8da4852d9bac859/propanc/files/theme/images/mgmt.jpg);background-position: 50% 50%;background-repeat: no-repeat;background-size: cover;> div classvertical-align> div classwrapper> a hrefhttps://ir.propanc.com/management-team classbig>View Management Team/a> /div> /div> /div> div classcol-sm-6 overlay stylebackground: url(https://d1io3yog0oux5.cloudfront.net/_061ec00376ee1bd8e8da4852d9bac859/propanc/files/theme/images/board-of-directors.jpg);background-position: 50% 50%;background-repeat: no-repeat;background-size: cover;> div classvertical-align> div classwrapper> a hrefhttps://ir.propanc.com/board-of-directors classbig>View Board of Directors/a> /div> /div> /div> /div> /div>/div>div classmodule ir-module contact-module extra-padding> div classcontainer> h2>IR Contact Information/h2> div classrow> div classcol-md-4> h5>Investor Relations/h5> p> strong>Propanc Biopharma, Inc./strong>br> T: +61-03-9882-6723br> a hrefmailto:irteam@propanc.com>irteam@propanc.com/a>br> /p> /div> div classcol-md-4> h5>Transfer Agent/h5> p> strong>Securities Transfer Corporation/strong>br> 2901 N. Dallas Parkwaybr> Suite 380br> Plano, Texas 75093br> T: 469-633-0101br> F: 469-633-0088br> a hrefhttp://www.stctransfer.com target_blank>www.stctransfer.com/a> /p> /div> /div> /div>/div>footer> div classcontainer> !--div classfooter-social> a href#>span classeqicon-social-01-linkedin>/span>/a> a href#>span classeqicon-social-01-twitter>/span>/a> a href#>span classeqicon-social-01-facebook>/span>/a> /div--> div classfooter-links> a href/privacy-policy>Privacy Policy/a> a href/disclaimer>Disclaimer/a> a href/sitemap>Sitemap/a> span classcopyright>©2026 a href/>Propanc Biopharma, Inc./a>/span> /div> /div>/footer>script idcompanyVars typeapplication/json>{ hCaptchaSiteKey: 778a5748-d323-4b73-a06c-9625642de8bc}/script>script srchttps://d1io3yog0oux5.cloudfront.net/_061ec00376ee1bd8e8da4852d9bac859/propanc/files/theme/js/_js/all.js>/script>script typetext/javascript> var jqxhr jq.get( https://www.propanc.com/api/v1/quote, function(data) { populateQuoteBox(data); });/script>script> var $buoop { c: 2 }; function $buo_f() { var e document.createElement(script); e.src //browser-update.org/update.min.js; document.body.appendChild(e); } try { document.addEventListener(DOMContentLoaded, $buo_f, false) } catch (e) { window.attachEvent(onload, $buo_f) }/script>script srchttps://d1io3yog0oux5.cloudfront.net/_061ec00376ee1bd8e8da4852d9bac859/propanc/files/theme/js/aside/_js/browser-check.min.js async>/script> /div>!-- //general-wrapper -->/body>
View on OTX
|
View on ThreatMiner
Please enable JavaScript to view the
comments powered by Disqus.
Data with thanks to
AlienVault OTX
,
VirusTotal
,
Malwr
and
others
. [
Sitemap
]